We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00317798
Recruitment Status : Completed
First Posted : April 25, 2006
Last Update Posted : August 30, 2011
Information provided by (Responsible Party):
JJ Ifthikharuddin, University of Rochester

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2011
  Study Completion Date : April 2011